Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Operating Leases (2019 - 2025)

Historic Operating Leases for Phibro Animal Health (PAHC) over the last 7 years, with Q4 2025 value amounting to $33.0 million.

  • Phibro Animal Health's Operating Leases rose 1643.3% to $33.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $33.0 million, marking a year-over-year increase of 1643.3%. This contributed to the annual value of $33.7 million for FY2025, which is 1278.62% up from last year.
  • Per Phibro Animal Health's latest filing, its Operating Leases stood at $33.0 million for Q4 2025, which was up 1643.3% from $33.1 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Operating Leases high stood at $33.7 million for Q2 2025, and its period low was $27.0 million during Q1 2021.
  • In the last 5 years, Phibro Animal Health's Operating Leases had a median value of $30.0 million in 2023 and averaged $30.3 million.
  • In the last 5 years, Phibro Animal Health's Operating Leases skyrocketed by 6589.27% in 2021 and then plummeted by 1062.08% in 2023.
  • Over the past 5 years, Phibro Animal Health's Operating Leases (Quarter) stood at $27.7 million in 2021, then rose by 7.49% to $29.8 million in 2022, then grew by 4.79% to $31.2 million in 2023, then dropped by 9.23% to $28.3 million in 2024, then increased by 16.43% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q4 2025, $33.1 million for Q3 2025, and $33.7 million during Q2 2025.